7: Lupus Flashcards
T/F SLE is an organ-specific disease like thyroiditis and diabetes.
False. It is a multisystem autoimmune disease that affects many organs.
Does SLE favor men or women?
Women (9:1)
When is the typical onset of SLE?
Reproductive years
T/F SLE has a strong minority representation.
True
What are constitutional symptoms of SLE (3)?
- Fatigue
- Fever
- Weight loss
What are SLE triggers (5)?
- Recent sun exposure.
- Emotional stress.
- Infection
- Drugs (sulfonamides, Hydralazine).
- Surgery
What is the criteria for diagnosing SLE (12)?
Must meet 4: Mucocutaneous: 1. Malar rash 2. Discoid lesions 3. Photosensitivity 4. Oral ulcers Symptomatic Organs: 5. Arthritis 6. Serositis 7. Neuropsychiatric 8. Renal Labs: 9. ANA 10. Hematological (lymphopenia, leukopenia, hemolytic anemia, thrombocytopenia) 11. Immunologic (anti-ds-DNA, anti-Smith, antiphospholipid) 12. Nephritis (RBC casts, proteinuria)
T/F SLE patients who die within 5 years usually have active disease.
True. Over 90% survive at least 2 years after diagnosis. Currently 80-90% survive 10 years. Late deaths are often d/t CVD.
T/F SLE is curable.
False. Remission is possible, but not a cure.
Which system is the most commonly affected?
Cutaneous (80-90%)
What are the 3 most common types of skin lesions with SLE?
- Acute
- Subacute
- Discoid (chronic)
What drugs can trigger SLE (6)?
- Clopidogrel
- Hydralazine
- Isoniazid
- Procainamide
- Ticlopidine
- Minocycline
Is a malar rash scarring?
No
What areas are important to inspect with SLE (6)?
- Scalp
- Pinnae
- Behind Ears
- Palate
- Fingertips
- Palms
T/F SLE can present with symmetrical arthritis just like RA.
True, but it can be brief or persistent, unlike RA.
The _____ is the signature organ affected by SLE.
Kidney
Studies all show _____ as key predictor of bad outcome.
Lupus nephritis
_____ affects 50-66% of patients.
Renal disease
What leads to diagnosis of renal disease in SLE?
Proteinuria
What is a very important test in SLE for health maintenance?
Urinalysis for protein
_____ manifestations in 66% of SLE patients.
Neuropsychiatric